Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

124,747 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prasugrel Dose De-escalation Therapy After Complex Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome: A Post Hoc Analysis From the HOST-REDUCE-POLYTECH-ACS Trial.
Hwang D, Lim YH, Park KW, Chun KJ, Han JK, Yang HM, Kang HJ, Koo BK, Kang J, Cho YK, Hong SJ, Kim S, Jo SH, Kim YH, Kim W, Lee SY, Kim YD, Oh SK, Lee JH, Kim HS; HOST-RP-ACS investigators. Hwang D, et al. Among authors: kim yh, kim w, kim s, kim yd, kim hs. JAMA Cardiol. 2022 Apr 1;7(4):418-426. doi: 10.1001/jamacardio.2022.0052. JAMA Cardiol. 2022. PMID: 35262625 Free PMC article. Clinical Trial.
Impact of lesion location on intravascular ultrasound findings and short-term and five-year long-term clinical outcome after percutaneous coronary intervention for saphenous vein graft lesions.
Hong YJ, Jeong MH, Ahn Y, Kang JC, Mintz GS, Kim SW, Lee SY, Kim SY, Pichard AD, Satler LF, Waksman R, Weissman NJ. Hong YJ, et al. Among authors: kim sw, kim sy. Int J Cardiol. 2013 Jul 15;167(1):29-33. doi: 10.1016/j.ijcard.2011.11.078. Epub 2011 Dec 20. Int J Cardiol. 2013. PMID: 22192289
Intravascular ultrasound analysis of plaque characteristics and postpercutaneous coronary intervention catheterization outcomes according to the remodeling pattern in narrowed saphenous vein grafts.
Hong YJ, Jeong MH, Ahn Y, Mintz GS, Kim SW, Lee SY, Kim SY, Cho JG, Park JC, Kang JC, Weissman NJ. Hong YJ, et al. Among authors: kim sw, kim sy. Am J Cardiol. 2012 Nov 1;110(9):1290-5. doi: 10.1016/j.amjcard.2012.06.031. Epub 2012 Jul 25. Am J Cardiol. 2012. PMID: 22835407
Comparison of antiplatelet efficacy and tolerability of clopidogrel napadisilate with clopidogrel bisulfate in coronary artery disease patients after percutaneous coronary intervention: a prospective, multicenter, randomized, open-label, phase IV, noninferiority trial.
Park JB, Koo BK, Choi WG, Kim SY, Park J, Kwan J, Park CG, Kim HS. Park JB, et al. Clin Ther. 2013 Jan;35(1):28-37.e4. doi: 10.1016/j.clinthera.2012.12.004. Clin Ther. 2013. PMID: 23328268 Clinical Trial.
Incidence, predictors, and clinical impact of tissue prolapse after stent implantation for saphenous vein graft disease: intravascular ultrasound study.
Hong YJ, Jeong MH, Ahn Y, Mintz GS, Kim SW, Lee SY, Kim SY, Cho JG, Park JC, Pichard AD, Satler LF, Waksman R, Kang JC, Weissman NJ. Hong YJ, et al. Among authors: kim sw, kim sy. Int J Cardiol. 2013 Oct 3;168(3):3073-5. doi: 10.1016/j.ijcard.2013.04.090. Epub 2013 Apr 28. Int J Cardiol. 2013. PMID: 23632113 No abstract available.
Harmonizing Optimal Strategy for Treatment of coronary artery diseases--comparison of REDUCtion of prasugrEl dose or POLYmer TECHnology in ACS patients (HOST-REDUCE-POLYTECH-ACS RCT): study protocol for a randomized controlled trial.
Lee JM, Jung JH, Park KW, Shin ES, Oh SK, Bae JW, Rhew JY, Lee N, Kim DB, Kim U, Han JK, Lee SE, Yang HM, Kang HJ, Koo BK, Kim S, Cho YK, Shin WY, Lim YH, Rha SW, Kim SY, Lee SY, Kim YD, Chae IH, Cha KS, Kim HS. Lee JM, et al. Among authors: kim u, kim s, kim sy, kim yd, kim hs, kim db. Trials. 2015 Sep 15;16:409. doi: 10.1186/s13063-015-0925-5. Trials. 2015. PMID: 26374625 Free PMC article. Clinical Trial.
Combination Therapy of Rosuvastatin and Ezetimibe in Patients with High Cardiovascular Risk.
Yang YJ, Lee SH, Kim BS, Cho YK, Cho HJ, Cho KI, Kim SY, Ryu JK, Cho JM, Park JI, Park JS, Park CG, Chun WJ, Kim MA, Jin DK, Lee N, Kim BJ, Koh KK, Suh J, Lee SH, Lee BK, Oh SJ, Jin HY, Ahn Y, Lee SG, Bae JH, Park WJ, Lee SC, Lee HC, Lee J, Park C, Lee B, Jang Y. Yang YJ, et al. Clin Ther. 2017 Jan;39(1):107-117. doi: 10.1016/j.clinthera.2016.11.014. Epub 2016 Dec 19. Clin Ther. 2017. PMID: 28007331 Clinical Trial.
The efficacy and safety of co-administration of fimasartan and rosuvastatin to patients with hypertension and dyslipidemia.
Rhee MY, Ahn T, Chang K, Chae SC, Yang TH, Shim WJ, Kang TS, Ryu JK, Nah DY, Park TH, Chae IH, Park SW, Lee HY, Tahk SJ, Yoon YW, Shim CY, Shin DG, Seo HS, Lee SY, Kim DI, Kwan J, Joo SJ, Jeong MH, Jeong JO, Sung KC, Kim SY, Kim SH, Chun KJ, Oh DJ. Rhee MY, et al. BMC Pharmacol Toxicol. 2017 Jan 5;18(1):2. doi: 10.1186/s40360-016-0112-7. BMC Pharmacol Toxicol. 2017. PMID: 28057081 Free PMC article. Clinical Trial.
124,747 results
You have reached the last available page of results. Please see the User Guide for more information.